Three roles people conflate: which one do you need?
A medical director is an organizational role: a physician responsible for clinical policies, protocols, and quality oversight of a program. A collaborating physician is a state-law arrangement enabling nurse practitioners to practice where full practice authority doesn't apply. A supervising physician oversees care delivered by other practitioners in defined settings under state rules. They are priced, contracted, and regulated differently, and 'we need a medical director' often turns out to mean one of the other two.
Which you need follows from who delivers your care and where. An NP-delivered program in restricted-practice states needs collaborating physicians in those states. A program with protocols, standing orders, or med-spa-style operations typically needs the director role. Many businesses need both, and the states you serve decide the count, which is why the multi-state number is so much bigger than the single-state one.
What does the market charge, per published anchors?
Read each published figure against the variable its source attaches it to, because they are not all the same variable. One placement service publishes entry pricing of around $799 per month per clinic for a single-provider arrangement, and markets that same starting price for nationwide placement, so it is a provider-count figure and not a single-state one. What that vendor does tie to footprint is $800 to $2,000 per month for a single-state telehealth practice and above $5,000 per month once an operation covers ten or more states, with nothing published in between. Drug schedule moves it separately: a single-provider weight-loss arrangement runs $799 to $1,200 per month until the program prescribes Schedule IV medications, at which point the same vendor quotes $2,000 to $4,000 per month. Collaborating-physician marketplaces publish state-level medians in the $499 to $599 per month range per NP relationship, with restricted states and specialty needs running higher.
The multipliers are what surprise founders: costs scale with states (each restricted state can mean another collaboration), with practitioner count (collaborations are per NP), and with involvement level (a signature-and-availability arrangement prices differently from real protocol ownership and chart review). A ten-state NP-delivered program can carry several oversight relationships at once, which is how 'about $800 a month' becomes a five-figure annual line before the first patient.
All figures here are third-party published or widely reported market anchors as of September 2026, for planning: your quotes will vary by state, specialty, and scope, and the breakeven calculator on this site lets you model your own configuration.
Price the role, not the title: states served, practitioners covered, and real involvement level move the number far more than the label does.
What does a good one do that a signature doesn't?
The market's quiet problem is the signature-only arrangement: a name on the paperwork, no protocol ownership, no chart review, no availability. Regulators, certification reviewers, and plaintiffs' lawyers all know the pattern, and it fails exactly when you need it to hold. Real oversight looks like owned protocols, defined chart-review cadence, availability for escalations, and documented involvement, which is also what the higher end of the price range is buying.
Vetting questions that separate the two in one call: how many programs do you currently direct, what does your monthly involvement look like in hours, what is your chart-review cadence, which of our protocols would you want to change, and what happened the last time you resigned from a program. Vague answers to the last two are the tell.
The make-or-buy reframe: when does the line item disappear?
The DIY path prices oversight as a standalone line: director fees plus per-NP collaborations, scaling with your state map. The operated-platform path prices it as part of the clinical layer: the medical group behind the platform already has directorship, collaboration coverage, and protocol governance across its states, and the partner never contracts for it separately. Neither is universally cheaper; the crossover depends on your states, practitioner mix, and volume.
The structural difference matters more than the monthly delta: on the DIY path, oversight quality is your hiring problem and your regulatory exposure; on the operated path it is the platform's operating discipline, inspected by every certification and diligence process the platform goes through. Founders who want to own that function should own it deliberately, with budget and vetting to match, not discover it as a formality.
Where does EmbedCare fit?
EmbedCare's clinical layer includes the medical group: 50-state clinician coverage with directorship, collaboration arrangements, and protocol governance operated as part of the platform, so partners launch without hiring oversight or pricing it state by state. If you are comparing paths, run your configuration through the medical-director breakeven calculator, then get the operated number in writing on a demo call.
Frequently asked
- Do I need a medical director for a telehealth business?
- It depends on your structure: programs with protocols and standing orders typically need the director role; NP-delivered care in restricted-practice states needs collaborating physicians (a different, per-state, per-NP arrangement); and on an operated platform with a built-in medical group, oversight is included rather than hired. Many DIY programs need both roles at once.
- How much does a medical director cost?
- Published entry pricing starts around $799 per month for a single-provider arrangement per clinic, offered for nationwide placement rather than for one state. Footprint and drug schedule move it from there: $800 to $2,000 per month for a single-state telehealth practice, above $5,000 per month at ten or more states, and $2,000 to $4,000 per month for weight-loss programs prescribing Schedule IV medications. Collaborating physicians run separately, with published state medians around $499 to $599 per month per NP. Figures are market anchors as of September 2026; states, practitioner count, and involvement level move them substantially.
- What's the difference between a medical director and a collaborating physician?
- A medical director owns clinical policies, protocols, and quality oversight for a program. A collaborating physician is a state-law arrangement that enables an NP to practice where full practice authority doesn't apply, contracted per NP and per state. Different roles, different pricing, and many programs need both.
- Can I use a signature-only medical director?
- It exists in the market and it is the arrangement that fails under scrutiny: certification reviewers, regulators, and litigation all probe for real involvement (protocol ownership, chart-review cadence, availability). If you hire the role, hire the real version; if you'd rather not manage it, that is what platforms with built-in medical groups are for.
- How do platforms include medical oversight?
- Operated platforms run their own medical group: directorship, collaboration coverage, and protocol governance across their states, maintained as part of the clinical layer partners launch on. The partner never contracts oversight separately, and the function is inspected through the platform's own certification and diligence processes.
Want pricing for your program, and the Rx menu that goes with this?
The partner overview in one email; a human follows up with pricing scoped to your program.